Integral Health Asset Management
Latest statistics and disclosures from Integral Health Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are THC, ARGX, BSX, MLTX, CYTK, and represent 20.92% of Integral Health Asset Management's stock portfolio.
- Added to shares of these 10 stocks: THC (+$20M), AMGN (+$18M), MDT (+$17M), BDX (+$17M), DXCM (+$16M), COR (+$15M), ARGX (+$15M), NARI (+$13M), MOH (+$12M), MLTX (+$11M).
- Started 24 new stock positions in TNDM, PFE, DXCM, ZTS, 89bio, BBIO, NBIX, SILK, CRNX, CTLT. MOH, AMGN, WW, AVTR, PACB, BDX, CABA, Sarepta Therapeutics Inc. cmn, NTRA, Moonlake Immunotherapeutics, WBA, ROIV, BPMC, MRK.
- Reduced shares in these 10 stocks: Novo-nordisk A S option (-$41M), CI (-$34M), ZBH (-$26M), , , SDGR (-$13M), GSK (-$13M), , Reata Pharmaceuticals Inc Cl A (-$12M), DHR (-$12M).
- Sold out of its positions in ABBV, ALLO, ALNY, FOLD, APLS, BMRN, BNTX, CNC, CCRN, DHR.
- Integral Health Asset Management was a net seller of stock by $-31M.
- Integral Health Asset Management has $722M in assets under management (AUM), dropping by -10.56%.
- Central Index Key (CIK): 0001773206
Tip: Access up to 7 years of quarterly data
Positions held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 65 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Tenet Healthcare Corp Com New (THC) | 4.9 | $36M | +132% | 540k | 65.89 |
|
| Argenx Se Sponsored Adr (ARGX) | 4.8 | $34M | +75% | 70k | 491.63 |
|
| Boston Scientific Corporation (BSX) | 4.0 | $29M | +18% | 550k | 52.80 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 3.9 | $29M | +66% | 500k | 57.00 |
|
| Cytokinetics Com New (CYTK) | 3.3 | $24M | +23% | 800k | 29.46 |
|
| Medtronic SHS (MDT) | 3.3 | $24M | +275% | 300k | 78.36 |
|
| Inari Medical Ord (NARI) | 3.2 | $23M | +125% | 350k | 65.40 |
|
| McKesson Corporation (MCK) | 3.0 | $22M | -30% | 50k | 434.85 |
|
| Inspire Med Sys (INSP) | 2.9 | $21M | 105k | 198.44 |
|
|
| Novartis Sponsored Adr (NVS) | 2.8 | $20M | +94% | 200k | 101.86 |
|
| AmerisourceBergen (COR) | 2.7 | $20M | +323% | 110k | 179.97 |
|
| Amgen (AMGN) | 2.4 | $18M | NEW | 65k | 268.76 |
|
| Cigna Corp (CI) | 2.4 | $17M | -66% | 60k | 286.07 |
|
| Becton, Dickinson and (BDX) | 2.3 | $17M | NEW | 65k | 258.53 |
|
| Encompass Health Corp (EHC) | 2.3 | $17M | +13% | 250k | 67.16 |
|
| Dex (DXCM) | 2.3 | $16M | NEW | 175k | 93.30 |
|
| Ventyx Biosciences (VTYX) | 2.1 | $15M | +22% | 430k | 34.73 |
|
| Revolution Medicines (RVMD) | 2.0 | $15M | +47% | 525k | 27.68 |
|
| Eli Lilly & Co. (LLY) | 1.9 | $13M | -16% | 25k | 537.13 |
|
| Crispr Therapeutics Namen Akt (CRSP) | 1.7 | $13M | +175% | 275k | 45.39 |
|
| Molina Healthcare (MOH) | 1.6 | $12M | NEW | 35k | 327.89 |
|
| Teladoc (TDOC) | 1.5 | $11M | +200% | 600k | 18.59 |
|
| PerkinElmer (RVTY) | 1.5 | $11M | -28% | 100k | 110.70 |
|
| Avantor (AVTR) | 1.5 | $11M | NEW | 525k | 21.08 |
|
| Anthem (ELV) | 1.5 | $11M | -16% | 25k | 435.42 |
|
| Si-bone (SIBN) | 1.4 | $10M | +113% | 485k | 21.24 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 1.4 | $10M | 1.0M | 10.20 |
|
|
| Guardant Health (GH) | 1.3 | $9.6M | -21% | 325k | 29.64 |
|
| Neurocrine Biosciences (NBIX) | 1.3 | $9.6M | NEW | 85k | 112.50 |
|
| Zentalis Pharmaceuticals (ZNTL) | 1.2 | $9.0M | 450k | 20.06 |
|
|
| Lifestance Health Group (LFST) | 1.2 | $8.9M | +68% | 1.3M | 6.87 |
|
| Viking Therapeutics (VKTX) | 1.2 | $8.9M | +9% | 800k | 11.07 |
|
| Natera (NTRA) | 1.2 | $8.9M | NEW | 200k | 44.25 |
|
| Hologic (HOLX) | 1.2 | $8.7M | -28% | 125k | 69.40 |
|
| Moonlake Immunotherapeutics Put Put Option | 1.2 | $8.6M | NEW | 150k | 57.00 |
|
| Elanco Animal Health (ELAN) | 1.2 | $8.4M | +274% | 748k | 11.24 |
|
| Krystal Biotech (KRYS) | 1.1 | $8.1M | +12% | 70k | 116.00 |
|
| Zimmer Holdings (ZBH) | 1.1 | $7.9M | -76% | 70k | 112.22 |
|
| Alkermes SHS (ALKS) | 1.1 | $7.7M | -3% | 275k | 28.01 |
|
| Catalent (CTLT) | 1.0 | $7.3M | NEW | 160k | 45.53 |
|
| Bridgebio Pharma (BBIO) | 1.0 | $7.3M | NEW | 275k | 26.37 |
|
| Intra Cellular Therapies (ITCI) | 1.0 | $6.9M | -6% | 133k | 52.09 |
|
| Relay Therapeutics (RLAY) | 0.9 | $6.7M | +14% | 800k | 8.41 |
|
| Pacific Biosciences of California (PACB) | 0.9 | $6.7M | NEW | 800k | 8.35 |
|
| Supernus Pharmaceuticals (SUPN) | 0.8 | $6.1M | +193% | 220k | 27.57 |
|
| Sarepta Therapeutics Call Call Option | 0.8 | $6.1M | NEW | 50k | 121.22 |
|
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $5.9M | NEW | 200k | 29.74 |
|
| Walgreen Boots Alliance (WBA) | 0.8 | $5.6M | NEW | 250k | 22.24 |
|
| Roivant Sciences SHS (ROIV) | 0.7 | $5.3M | NEW | 450k | 11.68 |
|
| Merck & Co (MRK) | 0.7 | $5.1M | NEW | 50k | 102.95 |
|
| Akero Therapeutics (AKRO) | 0.7 | $5.1M | +42% | 100k | 50.58 |
|
| Cabaletta Bio (CABA) | 0.7 | $5.0M | NEW | 330k | 15.22 |
|
| Pfizer (PFE) | 0.7 | $5.0M | NEW | 150k | 33.17 |
|
| Cooper Cos Com New | 0.7 | $4.8M | -71% | 15k | 318.01 |
|
| Replimune Group (REPL) | 0.6 | $4.3M | -43% | 250k | 17.11 |
|
| Longboard Pharmaceuticals In (LBPH) | 0.6 | $4.2M | +27% | 760k | 5.56 |
|
| Envista Hldgs Corp (NVST) | 0.6 | $4.2M | 150k | 27.88 |
|
|
| Zoetis Cl A (ZTS) | 0.5 | $3.5M | NEW | 20k | 173.98 |
|
| 89bio Call Call Option | 0.4 | $3.1M | NEW | 200k | 15.44 |
|
| Ww Intl (WW) | 0.4 | $2.8M | NEW | 250k | 11.07 |
|
| Tandem Diabetes Care Com New (TNDM) | 0.4 | $2.7M | NEW | 130k | 20.77 |
|
| Blueprint Medicines (BPMC) | 0.3 | $2.5M | NEW | 50k | 50.22 |
|
| Hca Holdings (HCA) | 0.3 | $2.5M | -75% | 10k | 245.98 |
|
| Silk Road Medical Inc Common (SILK) | 0.3 | $2.2M | NEW | 150k | 14.99 |
|
| Revance Therapeutics (RVNC) | 0.2 | $1.1M | -60% | 100k | 11.47 |
|
Past Filings by Integral Health Asset Management
SEC 13F filings are viewable for Integral Health Asset Management going back to 2019
- Integral Health Asset Management 2023 Q3 filed Nov. 14, 2023
- Integral Health Asset Management 2023 Q2 filed Aug. 11, 2023
- Integral Health Asset Management 2023 Q1 filed May 9, 2023
- Integral Health Asset Management 2022 Q4 filed Feb. 13, 2023
- Integral Health Asset Management 2022 Q3 filed Nov. 14, 2022
- Integral Health Asset Management 2022 Q2 filed Aug. 3, 2022
- Integral Health Asset Management 2022 Q1 filed May 12, 2022
- Integral Health Asset Management 2021 Q4 filed Feb. 2, 2022
- Integral Health Asset Management 2021 Q3 filed Nov. 12, 2021
- Integral Health Asset Management 2021 Q2 restated filed Aug. 30, 2021
- Integral Health Asset Management 2021 Q2 filed Aug. 13, 2021
- Integral Health Asset Management 2021 Q1 filed May 10, 2021
- Integral Health Asset Management 2020 Q4 filed Feb. 16, 2021
- Integral Health Asset Management 2020 Q3 filed Nov. 16, 2020
- Integral Health Asset Management 2020 Q2 filed Aug. 14, 2020
- Integral Health Asset Management 2020 Q1 filed May 15, 2020